Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/30/2025

Glutamine Supplementation in Anxiety

Safety Profile

  • Glutamine is the most abundant free amino acid in the body and is considered conditionally essential during certain states of illness or stress 1
  • No specific contraindications exist for glutamine supplementation in patients with anxiety disorders based on current clinical guidelines 2, 3

Physiological Considerations

  • Glutamine serves as a substrate for gluconeogenesis and participates in protein and glucose metabolism 1
  • It plays a role in the regulation of ammonia and acid-base balance 1

Dosing Considerations

  • Standard dosages used in clinical settings typically range from 0.3-0.6 g/kg/day of alanyl-glutamine dipeptide 1
  • For non-critically ill patients, lower doses are generally used, though specific guidelines for anxiety patients are not established 3

Potential Risks and Cautions

  • High-dose glutamine supplementation has been associated with increased mortality in critically ill patients with multi-organ failure 4, 5
  • Indiscriminate use of glutamine supplementation is not recommended based on recent evidence 6, 7
  • Patients with severe liver or kidney disease should use glutamine with caution due to its role in ammonia metabolism 1

Monitoring Recommendations

  • No specific monitoring parameters are required for glutamine supplementation in anxiety patients 3
  • Standard clinical follow-up to assess symptom changes and potential side effects is prudent 1
  • Patients should be advised to report any unusual symptoms or changes in anxiety levels 1

Conclusion for Clinical Practice

  • For most patients with anxiety, glutamine supplementation appears safe when used at standard doses 1
  • Avoid high-dose supplementation and use caution in patients with significant comorbidities, particularly liver or kidney disease 6, 4